[S02DA03, antipyrine, The serum concentration of Belzutifan can be increased when it is combined with Antipyrine.]
[G03XB02, ulipristal, The therapeutic efficacy of Ulipristal can be decreased when used in combination with Belzutifan.]
[J01EB06, sulfanilamide, The serum concentration of Belzutifan can be increased when it is combined with Sulfanilamide.]
[L02BA01, tamoxifen, The serum concentration of Tamoxifen can be decreased when it is combined with Belzutifan.]
[L01CB02, teniposide, The serum concentration of Teniposide can be decreased when it is combined with Belzutifan.]
[G03BA03, testosterone, The metabolism of Belzutifan can be decreased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Tetracaine.]
[A04AD10, dronabinol, The metabolism of Belzutifan can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The serum concentration of Belzutifan can be increased when it is combined with Thalidomide.]
[R03DA04, theophylline, The serum concentration of Theophylline can be decreased when it is combined with Belzutifan.]
[L01AC01, thiotepa, The serum concentration of Thiotepa can be decreased when it is combined with Belzutifan.]
[N05CA19, thiopental, The metabolism of Belzutifan can be decreased when combined with Thiopental.]
[N05AC02, thioridazine, The metabolism of Belzutifan can be decreased when combined with Thioridazine.]
[B01AC05, ticlopidine, The serum concentration of Belzutifan can be increased when it is combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Belzutifan can be decreased when combined with Timolol.]
[N06AF04, tranylcypromine, The serum concentration of Belzutifan can be increased when it is combined with Tranylcypromine.]
[N03AC02, trimethadione, The metabolism of Belzutifan can be decreased when combined with Trimethadione.]
[N06AX24, vilazodone, The metabolism of Belzutifan can be decreased when combined with Vilazodone.]
[L01EX04, vandetanib, The serum concentration of Vandetanib can be decreased when it is combined with Belzutifan.]
[L02BX03, abiraterone, The serum concentration of Belzutifan can be increased when it is combined with Abiraterone.]
[J05AG05, rilpivirine, The metabolism of Belzutifan can be decreased when combined with Rilpivirine.]
[C08DA01, verapamil, The metabolism of Belzutifan can be decreased when combined with Verapamil.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be decreased when it is combined with Belzutifan.]
[L01CA02, vincristine, The serum concentration of Vincristine can be decreased when it is combined with Belzutifan.]
[L01CA03, vindesine, The serum concentration of Vindesine can be decreased when it is combined with Belzutifan.]
[B01AA03, warfarin, The serum concentration of Warfarin can be decreased when it is combined with Belzutifan.]
[L01EC01, vemurafenib, The serum concentration of Vemurafenib can be decreased when it is combined with Belzutifan.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be decreased when it is combined with Belzutifan.]
[L01ED01, crizotinib, The serum concentration of Crizotinib can be decreased when it is combined with Belzutifan.]
[R03DC01, zafirlukast, The serum concentration of Belzutifan can be increased when it is combined with Zafirlukast.]
[A02BC04, rabeprazole, The serum concentration of Belzutifan can be increased when it is combined with Rabeprazole.]
[G03AC10, drospirenone, The therapeutic efficacy of Drospirenone can be decreased when used in combination with Belzutifan.]
[L01EJ01, ruxolitinib, The serum concentration of Ruxolitinib can be decreased when it is combined with Belzutifan.]
[J02AC03, voriconazole, The serum concentration of Belzutifan can be increased when it is combined with Voriconazole.]
[L01XJ01, vismodegib, The serum concentration of Belzutifan can be increased when it is combined with Vismodegib.]
[L01EK01, axitinib, The serum concentration of Axitinib can be decreased when it is combined with Belzutifan.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Belzutifan.]
[L02BB04, enzalutamide, The serum concentration of Belzutifan can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be decreased when it is combined with Belzutifan.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be decreased when it is combined with Belzutifan.]
[N05CA04, barbital, The metabolism of Belzutifan can be decreased when combined with Barbital.]
[G04BE03, sildenafil, The serum concentration of Belzutifan can be increased when it is combined with Sildenafil.]
[L01EA05, ponatinib, The serum concentration of Ponatinib can be decreased when it is combined with Belzutifan.]
[B01AF02, apixaban, The metabolism of Belzutifan can be decreased when combined with Apixaban.]
[C10AX12, lomitapide, The serum concentration of Lomitapide can be decreased when it is combined with Belzutifan.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be decreased when it is combined with Belzutifan.]
[M04AB03, benzbromarone, The serum concentration of Belzutifan can be increased when it is combined with Benzbromarone.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Benzocaine.]
[L04AA18, everolimus, The serum concentration of Everolimus can be decreased when it is combined with Belzutifan.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be decreased when it is combined with Belzutifan.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Benzyl alcohol.]
[N06AX26, vortioxetine, The metabolism of Belzutifan can be decreased when combined with Vortioxetine.]
[G03AC08, etonogestrel, The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Belzutifan.]
[N03AF04, eslicarbazepine, The serum concentration of Belzutifan can be increased when it is combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Belzutifan can be increased when it is combined with Luliconazole.]
[L04AA32, apremilast, The metabolism of Belzutifan can be increased when combined with Apremilast.]
[L04AC11, siltuximab, The metabolism of Belzutifan can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be decreased when it is combined with Belzutifan.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be decreased when it is combined with Belzutifan.]
[L01EM01, idelalisib, The serum concentration of Idelalisib can be decreased when it is combined with Belzutifan.]
[J01XA05, oritavancin, The serum concentration of Belzutifan can be increased when it is combined with Oritavancin.]
[L04AX05, pirfenidone, The metabolism of Belzutifan can be decreased when combined with Pirfenidone.]
[L01XK01, olaparib, The serum concentration of Olaparib can be decreased when it is combined with Belzutifan.]
[L04AC10, secukinumab, The metabolism of Belzutifan can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The serum concentration of Palbociclib can be decreased when it is combined with Belzutifan.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be decreased when it is combined with Belzutifan.]
[L01XJ02, sonidegib, The serum concentration of Sonidegib can be decreased when it is combined with Belzutifan.]
[A02BC03, lansoprazole, The serum concentration of Belzutifan can be increased when it is combined with Lansoprazole.]
[L01CX01, trabectedin, The serum concentration of Trabectedin can be decreased when it is combined with Belzutifan.]
[J02AC05, isavuconazole, The serum concentration of Belzutifan can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be decreased when it is combined with Belzutifan.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Belzutifan.]
[L01XG03, ixazomib, The serum concentration of Ixazomib can be decreased when it is combined with Belzutifan.]
[L01ED03, alectinib, The serum concentration of Alectinib can be decreased when it is combined with Belzutifan.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be decreased when it is combined with Belzutifan.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Bupivacaine.]
[N07BC01, buprenorphine, The serum concentration of Belzutifan can be increased when it is combined with Buprenorphine.]
[L01AB01, busulfan, The serum concentration of Busulfan can be decreased when it is combined with Belzutifan.]
[P01BE02, artemether, The metabolism of Belzutifan can be decreased when combined with Artemether.]
[M02AA03, clofezone, The serum concentration of Belzutifan can be increased when it is combined with Rabeprazole.]
[S01GX07, azelastine, The serum concentration of Belzutifan can be increased when it is combined with Azelastine.]
[L01XK03, rucaparib, The serum concentration of Belzutifan can be increased when it is combined with Rucaparib.]
[L01EF02, ribociclib, The serum concentration of Ribociclib can be decreased when it is combined with Belzutifan.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Oxybuprocaine.]
[J05AE09, tipranavir, The serum concentration of Belzutifan can be increased when it is combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Belzutifan can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The serum concentration of Midostaurin can be decreased when it is combined with Belzutifan.]
[L01ED04, brigatinib, The serum concentration of Brigatinib can be decreased when it is combined with Belzutifan.]
[N04BD03, safinamide, The serum concentration of Belzutifan can be increased when it is combined with Safinamide.]
[L01XX59, enasidenib, The serum concentration of Enasidenib can be decreased when it is combined with Belzutifan.]
[L01EH02, neratinib, The serum concentration of Neratinib can be decreased when it is combined with Belzutifan.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be decreased when it is combined with Belzutifan.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be decreased when it is combined with Belzutifan.]
[J05AG03, efavirenz, The serum concentration of Belzutifan can be increased when it is combined with Efavirenz.]
[L01EL02, acalabrutinib, The serum concentration of Acalabrutinib can be decreased when it is combined with Belzutifan.]
[J05AX18, letermovir, The metabolism of Belzutifan can be increased when combined with Letermovir.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Capsaicin.]
[L02BB05, apalutamide, The serum concentration of Belzutifan can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The serum concentration of Carbamazepine can be decreased when it is combined with Belzutifan.]
[N03AX24, cannabidiol, The serum concentration of Belzutifan can be increased when it is combined with Cannabidiol.]
[H01CC03, elagolix, The serum concentration of Belzutifan can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The serum concentration of Ivosidenib can be decreased when it is combined with Belzutifan.]
[N03AX17, stiripentol, The serum concentration of Belzutifan can be increased when it is combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Belzutifan can be decreased when combined with Tecovirimat.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be decreased when it is combined with Belzutifan.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Chloroprocaine.]
[M03BA02, carisoprodol, The metabolism of Belzutifan can be decreased when combined with Carisoprodol.]
[L04AA39, emapalumab, The metabolism of Belzutifan can be increased when combined with Emapalumab.]
[P02BX04, triclabendazole, The metabolism of Belzutifan can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Belzutifan can be decreased when combined with Esketamine.]
[L04AA42, siponimod, The serum concentration of Siponimod can be decreased when it is combined with Belzutifan.]
[L01EN01, erdafitinib, The serum concentration of Erdafitinib can be decreased when it is combined with Belzutifan.]
[N05BA09, clobazam, The metabolism of Belzutifan can be decreased when combined with Clobazam.]
[L04AB01, etanercept, The metabolism of Belzutifan can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be decreased when it is combined with Belzutifan.]
[L01EX15, pexidartinib, The serum concentration of Pexidartinib can be decreased when it is combined with Belzutifan.]
[L01EJ02, fedratinib, The metabolism of Belzutifan can be decreased when combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Entrectinib can be decreased when it is combined with Belzutifan.]
[G03DB05, demegestone, The therapeutic efficacy of Demegestone can be decreased when used in combination with Belzutifan.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Belzutifan.]
[L01EL03, zanubrutinib, The serum concentration of Zanubrutinib can be decreased when it is combined with Belzutifan.]
[G03AC09, desogestrel, The therapeutic efficacy of Desogestrel can be decreased when used in combination with Belzutifan.]
[B06AX03, voxelotor, The metabolism of Belzutifan can be decreased when combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Belzutifan can be increased when it is combined with Cenobamate.]
[H02CA02, osilodrostat, The serum concentration of Belzutifan can be increased when it is combined with Osilodrostat.]
[J05AE05, amprenavir, The serum concentration of Belzutifan can be increased when it is combined with Amprenavir.]
[L01EE04, selumetinib, The metabolism of Belzutifan can be decreased when combined with Selumetinib.]
[G03DB08, dienogest, The therapeutic efficacy of Dienogest can be decreased when used in combination with Belzutifan.]
[C08CA16, clevidipine, The serum concentration of Belzutifan can be increased when it is combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Dronedarone can be decreased when it is combined with Belzutifan.]
[S03AA08, chloramphenicol, The serum concentration of Belzutifan can be increased when it is combined with Chloramphenicol.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Dyclonine.]
[P01BB01, proguanil, The metabolism of Belzutifan can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Belzutifan can be decreased when it is combined with Satralizumab.]
[G03DC06, ethynodiol, The therapeutic efficacy of Etynodiol can be decreased when used in combination with Belzutifan.]
[A16AX20, lonafarnib, The serum concentration of Belzutifan can be increased when it is combined with Lonafarnib.]
[N03AX10, felbamate, The serum concentration of Belzutifan can be increased when it is combined with Felbamate.]
[R03CC15, formoterol, The metabolism of Belzutifan can be decreased when combined with Formoterol.]
[A02BA01, cimetidine, The serum concentration of Belzutifan can be increased when it is combined with Cimetidine.]
[N06AB04, citalopram, The serum concentration of Belzutifan can be increased when it is combined with Citalopram.]
[H01AC07, somapacitan, The serum concentration of Belzutifan can be increased when it is combined with Somapacitan.]
[P01CA03, fexinidazole, The serum concentration of Belzutifan can be increased when it is combined with Fexinidazole.]
[N06AX25, St. John's wort extract, The metabolism of Belzutifan can be decreased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Belzutifan can be decreased when combined with Asciminib.]
[D11AH08, abrocitinib, The metabolism of Belzutifan can be decreased when combined with Abrocitinib.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Levobupivacaine.]
[N06AA04, clomipramine, The serum concentration of Clomipramine can be decreased when it is combined with Belzutifan.]
[S01EA04, clonidine, The serum concentration of Clonidine can be decreased when it is combined with Belzutifan.]
[C01EB24, mavacamten, The serum concentration of Belzutifan can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The serum concentration of Belzutifan can be increased when it is combined with Vonoprazan.]
[N05AH02, clozapine, The serum concentration of Belzutifan can be increased when it is combined with Clozapine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Belzutifan can be increased when combined with Bimekizumab.]
[L01EA01, imatinib, The metabolism of Belzutifan can be decreased when combined with Imatinib.]
[A02BC05, esomeprazole, The serum concentration of Belzutifan can be increased when it is combined with Esomeprazole.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Belzutifan.]
[C08CA11, manidipine, The serum concentration of Belzutifan can be increased when it is combined with Manidipine.]
[L01AA01, cyclophosphamide, The serum concentration of Cyclophosphamide can be decreased when it is combined with Belzutifan.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be decreased when it is combined with Belzutifan.]
[N06AG02, moclobemide, The serum concentration of Belzutifan can be increased when it is combined with Moclobemide.]
[N06BA07, modafinil, The serum concentration of Belzutifan can be increased when it is combined with Modafinil.]
[C03XA02, conivaptan, The serum concentration of Conivaptan can be decreased when it is combined with Belzutifan.]
[M01AH05, etoricoxib, The serum concentration of Belzutifan can be increased when it is combined with Etoricoxib.]
[C07AB12, nebivolol, The metabolism of Belzutifan can be decreased when combined with Nebivolol.]
[L02BB02, nilutamide, The serum concentration of Belzutifan can be increased when it is combined with Nilutamide.]
[G03DB04, nomegestrol, The therapeutic efficacy of Nomegestrol can be decreased when used in combination with Belzutifan.]
[N06AB10, escitalopram, The metabolism of Belzutifan can be decreased when combined with Escitalopram.]
[N03AF02, oxcarbazepine, The serum concentration of Belzutifan can be increased when it is combined with Oxcarbazepine.]
[L04AB04, adalimumab, The metabolism of Belzutifan can be increased when combined with Adalimumab.]
[N06AB05, paroxetine, The metabolism of Belzutifan can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Belzutifan can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The serum concentration of Belzutifan can be increased when it is combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Cinchocaine.]
[L01DC04, ixabepilone, The serum concentration of Ixabepilone can be decreased when it is combined with Belzutifan.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Belzutifan.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Belzutifan.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be decreased when it is combined with Belzutifan.]
[N02CA01, dihydroergotamine, The serum concentration of Dihydroergotamine can be decreased when it is combined with Belzutifan.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Pramocaine.]
[M02AX03, dimethyl sulfoxide, The serum concentration of Belzutifan can be increased when it is combined with Dimethyl sulfoxide.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Diphenhydramine.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be decreased when it is combined with Belzutifan.]
[S02AA12, rifamycin SV, The serum concentration of Belzutifan can be increased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Belzutifan can be increased when combined with Rifapentine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Ropivacaine.]
[L01EX01, sunitinib, The serum concentration of Sunitinib can be decreased when it is combined with Belzutifan.]
[A04AD12, aprepitant, The serum concentration of Belzutifan can be increased when it is combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be decreased when it is combined with Belzutifan.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be decreased when it is combined with Belzutifan.]
[N06AA16, dothiepin, The serum concentration of Belzutifan can be increased when it is combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Belzutifan can be decreased when combined with Doxepin.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be decreased when it is combined with Belzutifan.]
[N06AB06, sertraline, The serum concentration of Belzutifan can be increased when it is combined with Sertraline.]
[N06AX14, tianeptine, The serum concentration of Tianeptine can be decreased when it is combined with Belzutifan.]
[G01AF08, tioconazole, The serum concentration of Belzutifan can be increased when it is combined with Tioconazole.]
[N03AX11, topiramate, The serum concentration of Belzutifan can be increased when it is combined with Topiramate.]
[L01CA04, vinorelbine, The serum concentration of Vinorelbine can be decreased when it is combined with Belzutifan.]
[N05CF02, zolpidem, The metabolism of Belzutifan can be decreased when combined with Zolpidem.]
[N03AX15, zonisamide, The serum concentration of Belzutifan can be increased when it is combined with Zonisamide.]
[N02CA02, ergotamine, The serum concentration of Ergotamine can be decreased when it is combined with Belzutifan.]
[A02BC02, pantoprazole, The serum concentration of Belzutifan can be increased when it is combined with Pantoprazole.]
[G03CA03, estradiol, The therapeutic efficacy of Estradiol can be decreased when used in combination with Belzutifan.]
[J04AK02, ethambutol, The metabolism of Belzutifan can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The serum concentration of Belzutifan can be increased when it is combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The serum concentration of Belzutifan can be increased when it is combined with Ethinylestradiol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be decreased when it is combined with Belzutifan.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be decreased when it is combined with Belzutifan.]
[R06AX11, astemizole, The serum concentration of Astemizole can be decreased when it is combined with Belzutifan.]
[N06AB08, fluvoxamine, The serum concentration of Belzutifan can be increased when it is combined with Fluvoxamine.]
[P02CA03, albendazole, The metabolism of Belzutifan can be decreased when combined with Albendazole.]
[J02AC01, fluconazole, The serum concentration of Belzutifan can be increased when it is combined with Fluconazole.]
[V03AZ01, ethanol, The serum concentration of Belzutifan can be increased when it is combined with Ethanol.]
[N06AB03, fluoxetine, The serum concentration of Belzutifan can be increased when it is combined with Fluoxetine.]
[C10AB04, gemfibrozil, The serum concentration of Belzutifan can be increased when it is combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be decreased when it is combined with Belzutifan.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be decreased when it is combined with Belzutifan.]
[J05AG04, etravirine, The serum concentration of Belzutifan can be increased when it is combined with Etravirine.]
[N03AD03, methsuximide, The serum concentration of Belzutifan can be increased when it is combined with Methsuximide.]
[G03XA02, gestrinone, The therapeutic efficacy of Gestrinone can be decreased when used in combination with Belzutifan.]
[L01EH01, lapatinib, The metabolism of Belzutifan can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Belzutifan can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Belzutifan can be decreased when combined with Gliclazide.]
[C01BD04, dofetilide, The serum concentration of Dofetilide can be decreased when it is combined with Belzutifan.]
[C02CA04, doxazosin, The metabolism of Belzutifan can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The serum concentration of Sorafenib can be decreased when it is combined with Belzutifan.]
[L01CE02, irinotecan, The serum concentration of Irinotecan can be decreased when it is combined with Belzutifan.]
[C09CA01, losartan, The serum concentration of Belzutifan can be increased when it is combined with Losartan.]
[N05CA16, hexobarbital, The metabolism of Belzutifan can be decreased when combined with Hexobarbital.]
[C08CA10, nilvadipine, The serum concentration of Belzutifan can be increased when it is combined with Nilvadipine.]
[J04AB04, rifabutin, The metabolism of Belzutifan can be increased when combined with Rifabutin.]
[L01AA06, ifosfamide, The serum concentration of Ifosfamide can be decreased when it is combined with Belzutifan.]
[N06AA02, imipramine, The serum concentration of Belzutifan can be increased when it is combined with Imipramine.]
[L01CD01, paclitaxel, The serum concentration of Paclitaxel can be decreased when it is combined with Belzutifan.]
[S01BC01, indomethacin, The serum concentration of Belzutifan can be increased when it is combined with Indomethacin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Articaine.]
[N05CH02, ramelteon, The metabolism of Belzutifan can be decreased when combined with Ramelteon.]
[J04AC01, isoniazid, The serum concentration of Belzutifan can be increased when it is combined with Isoniazid.]
[H01AC01, somatropin, The serum concentration of Belzutifan can be increased when it is combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Belzutifan can be increased when combined with Tocilizumab.]
[J02AB02, ketoconazole, The serum concentration of Belzutifan can be increased when it is combined with Ketoconazole.]
[N05AH03, olanzapine, The serum concentration of Belzutifan can be increased when it is combined with Olanzapine.]
[L04AA24, abatacept, The metabolism of Belzutifan can be increased when combined with Abatacept.]
[C07AG01, labetalol, The metabolism of Belzutifan can be decreased when combined with Labetalol.]
[N03AX18, lacosamide, The metabolism of Belzutifan can be decreased when combined with Lacosamide.]
[G03AD01, levonorgestrel, The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Belzutifan.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Lidocaine.]
[N06BA13, armodafinil, The serum concentration of Belzutifan can be increased when it is combined with Armodafinil.]
[G03DC03, lynestrenol, The serum concentration of Belzutifan can be increased when it is combined with Lynestrenol.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be decreased when it is combined with Belzutifan.]
[L01EA03, nilotinib, The serum concentration of Nilotinib can be decreased when it is combined with Belzutifan.]
[N06DX01, memantine, The serum concentration of Belzutifan can be increased when it is combined with Memantine.]
[N03AB04, mephenytoin, The serum concentration of Belzutifan can be increased when it is combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Belzutifan can be decreased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Mepivacaine.]
[N07BC02, methadone, The metabolism of Belzutifan can be decreased when combined with Methadone.]
[H03BB02, methimazole, The serum concentration of Belzutifan can be increased when it is combined with Methimazole.]
[L04AX03, methotrexate, The serum concentration of Methotrexate can be decreased when it is combined with Belzutifan.]
[V04CG05, methylene blue, The serum concentration of Belzutifan can be increased when it is combined with Methylene blue.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be decreased when it is combined with Belzutifan.]
[S02AA13, miconazole, The serum concentration of Belzutifan can be increased when it is combined with Miconazole.]
[N02BB03, aminopyrine, The serum concentration of Belzutifan can be increased when it is combined with Aminophenazone.]
[G03XB01, mifepristone, The therapeutic efficacy of Mifepristone can be decreased when used in combination with Belzutifan.]
[C01BD01, amiodarone, The serum concentration of Amiodarone can be decreased when it is combined with Belzutifan.]
[N06AA09, amitriptyline, The serum concentration of Belzutifan can be increased when it is combined with Amitriptyline.]
[L04AB05, certolizumab pegol, The metabolism of Belzutifan can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be decreased when it is combined with Belzutifan.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be decreased when it is combined with Belzutifan.]
[L04AC03, anakinra, The metabolism of Belzutifan can be increased when combined with Anakinra.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Belzutifan.]
[L01CD02, docetaxel, The serum concentration of Docetaxel can be decreased when it is combined with Belzutifan.]
[L02BG04, letrozole, The serum concentration of Belzutifan can be increased when it is combined with Letrozole.]
[C09CA07, telmisartan, The serum concentration of Belzutifan can be increased when it is combined with Telmisartan.]
[C08CA04, nicardipine, The serum concentration of Belzutifan can be increased when it is combined with Nicardipine.]
[G03DC02, norethindrone, The therapeutic efficacy of Norethisterone can be decreased when used in combination with Belzutifan.]
[G03AC07, norgestrienone, The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Belzutifan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be decreased when it is combined with Belzutifan.]
[L04AC04, rilonacept, The metabolism of Belzutifan can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The serum concentration of Belzutifan can be increased when it is combined with Omeprazole.]
[G03DB06, chlormadinone, The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Belzutifan.]
[N05CA01, pentobarbital, The metabolism of Belzutifan can be decreased when combined with Pentobarbital.]
[N06AF03, phenelzine, The serum concentration of Belzutifan can be increased when it is combined with Phenelzine.]
[N03AA02, phenobarbital, The metabolism of Belzutifan can be decreased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The serum concentration of Phenprocoumon can be decreased when it is combined with Belzutifan.]
[A02BC06, dexlansoprazole, The metabolism of Belzutifan can be decreased when combined with Dexlansoprazole.]
[N03AB02, phenytoin, The metabolism of Belzutifan can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Belzutifan can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The serum concentration of Bicalutamide can be decreased when it is combined with Belzutifan.]
[N05AG02, pimozide, The serum concentration of Pimozide can be decreased when it is combined with Belzutifan.]
[J05AG02, delavirdine, The serum concentration of Belzutifan can be increased when it is combined with Delavirdine.]
[L04AC08, canakinumab, The metabolism of Belzutifan can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Belzutifan can be increased when it is combined with Ritonavir.]
[P02BA01, praziquantel, The metabolism of Belzutifan can be decreased when combined with Praziquantel.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Prilocaine.]
[N03AA03, primidone, The metabolism of Belzutifan can be decreased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Belzutifan can be increased when it is combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Procaine.]
[C10AB05, fenofibrate, The serum concentration of Belzutifan can be increased when it is combined with Fenofibrate.]
[G03DA04, progesterone, The serum concentration of Belzutifan can be increased when it is combined with Progesterone.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be decreased when it is combined with Belzutifan.]
[C07AA05, propranolol, The metabolism of Belzutifan can be decreased when combined with Propranolol.]
[C01BA01, quinidine, The serum concentration of Quinidine can be decreased when it is combined with Belzutifan.]
[P01BC01, quinine, The serum concentration of Belzutifan can be increased when it is combined with Quinine.]
[J04AB02, rifampin, The metabolism of Belzutifan can be increased when combined with Rifampicin.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be decreased when it is combined with Belzutifan.]
[N03AG01, valproic acid, The serum concentration of Belzutifan can be increased when it is combined with Valproic acid.]
